News

Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Recognizes One-Year Anniversary of First RSHO-X™ Import Permit

January 31, 2017

general-hemp-blog-rsho-x-11-28-16-ver1

SAN DIEGO, Jan. 31, 2017  — Medical Marijuana, Inc. (OTC PINK: MJNA), the first publicly traded cannabis company in the United States, is proud to announce the progress made by subsidiary HempMeds® Mexico upon the one-year anniversary of the first-ever import

Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Launches New Website

January 30, 2017

general-hemp-blog-images-01-30-17-ver1

SAN DIEGO, Jan. 30, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC PINK:MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Mexico has launched its new website, featuring a fresh interface, educational info, and online

Medical Marijuana, Inc. Subsidiary Kannaway® Announces Launch of a New Product- “Kannaway® Gold Premium Hemp Oil”

January 25, 2017

general-hemp-blog-hemp-plant-01-17-25-ver1

New Hemp Oil Product is Company’s Highest Potency Product and is Available Now in 15-gram Tube SAN DIEGO, Jan. 25, 2017 /PRNewswire/ — Medical Marijuana, Inc. MJNA, +6.62%announced today that its subsidiary Kannaway®, LLC, the first hemp lifestyle network to offer

Medical Marijuana, Inc. Subsidiary HempMeds Mexico® Receives COFEPRIS Permission for Flagship Product RSHO-X™ Usage for Cancer Patient

January 24, 2017

general-hemp-blog-rsho-x-11-28-16-ver1

Patient Received Permission to Be Treated with RSHO-X™ for Pain Associated with Cancer Treatment and General Well-Being SAN DIEGO, Jan. 24, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary HempMeds Mexico® has received permission from Mexico’s

Medical Marijuana, Inc. Featured in International Business Times Article Highlighting RSHO-X and the State of the Global Cannabis Industry

January 23, 2017

general-hemp-blog-tablet-with-chart-11-13-16-ver1

Dr. Stuart Titus Speaks on RSHO-X’s Benefits and Cannabis Industry Updates Around the World SAN DIEGO, Jan. 23, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC PINK:MJNA), the first-ever publicly traded cannabis company in the United States, was recently featured in an

AXIM® Biotech Enters IBS Clinical Trial for CanChew CBD Chewing Gum

January 18, 2017

general-hemp-blog-images-11-16-16-ver1

NEW YORK, Jan 18, 2017 (GLOBE NEWSWIRE via COMTEX) — AXIM® Biotechnologies, Inc. (AXIM® Biotech) AXIM, +25.67% a world leader in cannabinoid research and development, entered a clinical trial on treating irritable bowel syndrome (IBS) with the company’s CanChew Plus®

Medical Marijuana, Inc. Welcomes New Vice President of Data & Technology, Dirk Syburra

January 17, 2017

general-hemp-blog-images-17-01-17-ver1

SAN DIEGO, Jan. 17, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC PINK:MJNA), the first-ever publicly traded cannabis company in the United States, today announced that Dirk Syburra has been promoted to Vice President of Data & Technology for the company. In

Medical Marijuana, Inc. Subsidiary Kannaway® Announces Exclusive Red Carpet Event in Atlanta, Georgia

January 13, 2017

general-hemp-blog-blur-people-sitting-17-01-13-ver1

Portfolio Company and First Hemp Lifestyle Network to Offer Cannabidiol (CBD) Products to Give Sneak Peak on New Products, Brand and Incentives SAN DIEGO, Jan. 13, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA) announced today that its subsidiary, Kannaway LLC, the

Phoenix TV, One of China”s Largest TV Networks, Features Interviews with Medical Marijuana, Inc. CEO Stuart Titus Discussing the Economic Impact of CBD Products

January 11, 2017

general-hemp-blog-news-conference-11-18-16-ver1

Interview Portrays the Benefits of Cannabis-Related Products to Millions of Chinese Viewers Around the World SAN DIEGO, Jan. 11, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA) is pleased to announce that the Company’s CEO was featured in a series of interviews

AXIM® Biotech Attends Biotech Showcase and J.P. Morgan Healthcare Conferences in San Francisco

January 10, 2017

general-hemp-blog-medical-cannabis-17-01-10-ver1

NEW YORK, Jan 10, 2017 — AXIM Biotechnologies, Inc. (AXIM Biotech) AXIM, +23.30% a world leader in cannabinoid research and development, today announced that George E. Anastassov, MD, DDS, MBA and Chief Executive Officer of AXIM Biotech, is meeting with